• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者脑病理Braak分期的氢质子磁共振波谱评估

Evaluation of the Braak staging of brain pathology with H-MRS in patients with Parkinson's disease.

作者信息

Cao Hongmei, Shi Jie, Cao Bingqing, Kang Bei, Zhang Ming, Qu Qiumin

机构信息

Department of Neurology, The First Affiliated Hospital of Medical College of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi 710061, China.

Department of Neurology, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi 710004, China.

出版信息

Neurosci Lett. 2017 Nov 1;660:57-62. doi: 10.1016/j.neulet.2017.08.050. Epub 2017 Aug 24.

DOI:10.1016/j.neulet.2017.08.050
PMID:28844732
Abstract

The Braak staging of Parkinson's disease (PD) pathology is usually based on the brain autopsy, which has not been confirmed in living patients of PD. In this study, we investigated the metabolites of medulla oblongata, substantia nigra (SN), putamen, and motor cortex by measuring N-acetylaspartate (NAA), choline-containing compounds (Cho) and creatine (Cr) in 22 patients of PD and 15 age-matched healthy controls, using single-voxel H-magnetic resonance spectroscopy (H-MRS). The results showed that NAA/Cr in SN was lower in PD group than that in control group (p=0.006), however, there was no difference for NAA/Cr and Cho/Cr between PD group and control group in other regions. In SN, NAA/Cr was negatively correlated with Unified Parkinson's Disease Rating Scale (UPDRS) (r=-0.743, p=0.002) and Hoehn-Yahr staging (r=-0.714, p=0.003), while Cho/Cr was positively correlated with UPDRS (r=0.850, p<0.001) and Hoehn-Yahr staging (r=0.647, p=0.009). In PD group, the variance of NAA/Cr in SN was significantly larger than that in other regions (p=0.005), but there was no difference for the variance of Cho/Cr among regions of interesting (ROIs) (p=0.267). These results indicate that SN is the most seriously injured region in PD, and the metabolites in SN measured by H-MRS is correlated with the severity of PD. However, the Braak staging of PD pathology is not validated by H-MRS.

摘要

帕金森病(PD)病理的Braak分期通常基于脑尸检,这在PD的活体患者中尚未得到证实。在本研究中,我们通过使用单体素氢磁共振波谱(H-MRS)测量22例PD患者和15例年龄匹配的健康对照者延髓、黑质(SN)、壳核和运动皮层的代谢物,包括N-乙酰天门冬氨酸(NAA)、含胆碱化合物(Cho)和肌酸(Cr)。结果显示,PD组SN中的NAA/Cr低于对照组(p = 0.006),然而,PD组和对照组在其他区域的NAA/Cr和Cho/Cr没有差异。在SN中,NAA/Cr与统一帕金森病评定量表(UPDRS)呈负相关(r = -0.743,p = 0.002)和Hoehn-Yahr分期呈负相关(r = -0.714,p = 0.003),而Cho/Cr与UPDRS呈正相关(r = 0.850,p < 0.001)和Hoehn-Yahr分期呈正相关(r = 0.647,p = 0.009)。在PD组中,SN中NAA/Cr的方差显著大于其他区域(p = 0.005),但感兴趣区域(ROIs)之间Cho/Cr的方差没有差异(p = 0.267)。这些结果表明,SN是PD中损伤最严重的区域,通过H-MRS测量的SN中的代谢物与PD的严重程度相关。然而,PD病理的Braak分期未通过H-MRS得到验证。

相似文献

1
Evaluation of the Braak staging of brain pathology with H-MRS in patients with Parkinson's disease.帕金森病患者脑病理Braak分期的氢质子磁共振波谱评估
Neurosci Lett. 2017 Nov 1;660:57-62. doi: 10.1016/j.neulet.2017.08.050. Epub 2017 Aug 24.
2
Detection and application of neurochemical profile by multiple regional H-MRS in Parkinson's disease.通过多区域 H-MRS 检测和应用神经化学谱在帕金森病中的研究。
Brain Behav. 2017 Aug 13;7(9):e00792. doi: 10.1002/brb3.792. eCollection 2017 Sep.
3
Brain proton magnetic resonance spectroscopy in patients with Parkinson's disease.帕金森病患者的脑质子磁共振波谱分析
Curr J Neurol. 2022 Jul 6;21(3):156-161. doi: 10.18502/cjn.v21i3.11108.
4
Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease.质子磁共振波谱在帕金森病黑质代谢物中的应用。
Brain Imaging Behav. 2014 Mar;8(1):97-101. doi: 10.1007/s11682-013-9251-2.
5
Proton MR Spectroscopy for Monitoring Pathologic Changes in the Substantia Nigra and Globus Pallidus in Parkinson Disease.质子磁共振波谱在帕金森病黑质和苍白球病理变化监测中的应用。
AJR Am J Roentgenol. 2016 Feb;206(2):385-9. doi: 10.2214/AJR.14.14052.
6
Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study.多巴胺能治疗后新发帕金森病的代谢变化:一项质子磁共振波谱研究。
Neurosci Lett. 2015 Jul 10;599:55-60. doi: 10.1016/j.neulet.2015.05.044. Epub 2015 May 22.
7
The usage of proton magnetic resonance spectroscopy in Parkinson's disease.质子磁共振波谱在帕金森病中的应用。
J Med Assoc Thai. 2012 Jul;95(7):949-52.
8
Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.采用定量磁化率映射技术对帕金森病患者黑质内铁沉积进行定量分析。
J Neurol Sci. 2018 Mar 15;386:46-52. doi: 10.1016/j.jns.2018.01.008. Epub 2018 Jan 12.
9
Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.应用概率追踪技术评估帕金森病纹状体-黑质连接。
Neuroimage Clin. 2017 Sep 9;16:557-563. doi: 10.1016/j.nicl.2017.09.009. eCollection 2017.
10
Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.黑质神经黑色素作为帕金森病疾病进展的影像学生物标志物
J Parkinsons Dis. 2017;7(3):491-501. doi: 10.3233/JPD-171135.

引用本文的文献

1
Applications of magnetic resonance spectroscopy in diagnosis of neurodegenerative diseases: A systematic review.磁共振波谱在神经退行性疾病诊断中的应用:一项系统综述。
Heliyon. 2024 Apr 30;10(9):e30521. doi: 10.1016/j.heliyon.2024.e30521. eCollection 2024 May 15.
2
Brain proton magnetic resonance spectroscopy in patients with Parkinson's disease.帕金森病患者的脑质子磁共振波谱分析
Curr J Neurol. 2022 Jul 6;21(3):156-161. doi: 10.18502/cjn.v21i3.11108.
3
Comparative study of bilateral putamen for patients with severe Parkinson's disease detected by H magnetic resonance spectroscopy.
采用氢磁共振波谱对重度帕金森病患者双侧壳核的对比研究。
Quant Imaging Med Surg. 2023 Oct 1;13(10):6646-6655. doi: 10.21037/qims-23-231. Epub 2023 Aug 22.
4
A comparative study of posterior cingulate metabolism in patients with mild cognitive impairment due to Parkinson's disease or Alzheimer's disease.帕金森病或阿尔茨海默病所致轻度认知障碍患者后扣带回代谢的对比研究。
Sci Rep. 2023 Aug 30;13(1):14241. doi: 10.1038/s41598-023-41569-5.
5
How should we be using biomarkers in trials of disease modification in Parkinson's disease?我们应该如何在帕金森病疾病修饰治疗的临床试验中使用生物标志物?
Brain. 2023 Dec 1;146(12):4845-4869. doi: 10.1093/brain/awad265.
6
Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.帕金森病和非典型帕金森综合征的神经影像学进展
Front Neurol. 2020 Oct 15;11:572976. doi: 10.3389/fneur.2020.572976. eCollection 2020.
7
Altered Neurometabolic Profile in Early Parkinson's Disease: A Study With Short Echo-Time Whole Brain MR Spectroscopic Imaging.早期帕金森病的神经代谢特征改变:一项采用短回波时间全脑磁共振波谱成像的研究。
Front Neurol. 2019 Jul 17;10:777. doi: 10.3389/fneur.2019.00777. eCollection 2019.